1. Clinical Presentation, Pathology Evaluation

  2. Chemotherapy Regimens in Adjuvant Setting

  3. Approach to Stage 3

  4. Approach to Stage 2

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references recommended to read related to this specific episode:

  1. Practice Tools for the prognostic of Colorectal Cancer. Accessed April 2, 2022. https://oncologypro.esmo.org/oncology-in-practice/practice-tools/colorectal-cancer-prognosis

  2. Haller DG et al. Ann Oncol. 2015;26(4):715-724. doi:10.1093/ANNONC/MDV003

  3. Babcock BD et al. Ann Surg Oncol. 2018;25(7):1980-1985. doi:10.1245/S10434-018-6484-8

  4. Moertel CG et al. NEJM. 2010;322(6):352-358. doi:10.1056/NEJM199002083220602

  5. Ribic CM et al. NEJM. 2003;349(3):247-257. doi:10.1056/NEJMOA022289

  6. Haller DG et al. J Clin Oncol. 2005;23(34):8671-8678. doi:10.1200/JCO.2004.00.5686

  7. Kuebler JP et al. J Clin Oncol. 2007;25(16):2198-2204. doi:10.1200/JCO.2006.08.2974

  8. André T et al. J Clin Oncol. 2009;27(19):3109-3116. doi:10.1200/JCO.2008.20.6771

  9. Sargent DJ et al. J Clin Oncol. 2005;23(34):8664-8670. doi:10.1200/JCO.2005.01.6071

  10. Kannarkatt J et al. J Oncol Pract. 2017;13(4):233-241. doi:10.1200/JOP.2016.017210

  11. Grothey A et al. NEJM. 2018;378(13):1177-1188.

  12. André T et al. Lancet Oncol. 2020;21(12):1620-1629. doi:10.1016/S1470-2045(20)30527-1

  13. André T et al. J Clin Oncol. 2009;27(19):3109-3116. doi:10.1200/JCO.2008.20.6771

  14. André T et al. Oxaliplatin, NEJM 2009;350(23):2343-2351. doi:10.1056/NEJMOA032709

  15. Buyse M et al. Stat Methods Med Res. 2008;17(5):467-475. doi:10.1177/0962280207081864

  16. Sargent D et al. Eur J Cancer. 2011;47(7):990. doi:10.1016/J.EJCA.2010.12.015

  17. Gray R et al. Lancet. 2007;370(9604):2020-2029. doi:10.1016/S0140-6736(07)61866-2

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.

See All 47 Episodes of "Talking About Tumors with Ryann and Ryan"